If pt deemed to require anticoagulant but has intracranial bleeding risk,2 consider dabigatran, rivaroxaban, or apixaban4 [B]

By vgreene, 21 May, 2015

Exclude Patient Type Detail Header

No

Detail Type

Text

Detail Text

Dabigatran 150 mg BID if CrCl>30 or 75 mg bid if CrCl 15-305

Rivaroxaban 20 mg daily if CrCl ≥50 or 15 mg daily if CrCl 30-495

Apixaban 5 mg bid if SCr 1.5 and

Patient Type Detail Header (Long)

If pt deemed to require anticoagulant but has intracranial bleeding risk,<sup>2</sup> consider dabigatran, rivaroxaban, or apixaban<sup>4</sup> [B]

Stay Connected

Facebook Twitter YouTube